IMMUNOGENICITY IN PRECLINICAL DRUG DEVELOPMENT: STRATEGIES, RISKS, AND IMPLICATIONS FOR LARGE MOLECULE-BASED BIOLOGICS INCLUDING CAR T-CELL AND GENE THERAPIES

Sagarkumar Patel(National Institute of Pharmaceutical Education and Research), Ashok H Akabari(Manubhai Patel Dental College and Hospital), Rachna Patel(LabCorp (United States))
Unknown
March 14, 2023
10.53555/jptcp.v30i3.2784
Cited by 0

Related Papers

Simultaneous Estimation of Fimasartan potassium trihydrate and Atorvastatin calcium with Greenness Assessment using HPLC and UV Spectrophotometric Methods
|Green Analytical Chemistry|2023|41
Novel imidazopyrimidines-based molecules induce tetramerization of tumor pyruvate kinase M2 and exhibit potent antiproliferative profile
|European Journal of Pharmaceutical Sciences|2021|39
Analytical quality by design (AQbD) methodology for concurrent determination of perindopril erbumine and moxonidine hydrochloride using RP-HPLC with an eco-friendly evaluation
|Discover Chemistry.|2025|37
Stability-Indicating TLC-Densitometric and HPLC Methods for Simultaneous Determination of Teneligliptin and Pioglitazone in Pharmaceutical Dosage Forms with Eco-Friendly Assessment
|Journal of Chromatographic Science|2024|29
Eco‐Friendly RP‐HPLC Method for Simultaneous Estimation of Amlodipine Besylate and Indapamide: Analytical Quality by Design Approach and Greenness Assessment
|Separation Science Plus|2025|28